The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...

(NEXSTAR) – News is developing so quickly when it comes to COVID-19 booster shots, it can be hard to keep track of what’s happening. Have they been approved? Am I eligible? When can I get one? The ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

The U.S. Food and Drug Administration has approved emergency use authorization for a booster shot of the Pfizer-BioNTech vaccine to be given at least six months after completion of the second dose for ...

The U.S. will likely start to widely distribute Pfizer Covid-19 booster shots during the week of Sept. 20, but the rollout for Moderna's vaccine could be delayed, White House chief medical advisor Dr.

WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...

NEW YORK (WABC) -- The European Union's drug regulator gave its backing to administering booster shots of the Pfizer-BioNTech COVID-19 vaccine for people 18 and older. The European Medicines Agency ...

NEW YORK -- In the next month, millions of Americans will get ready to roll up their sleeves for a third dose of the COVID-19 vaccine. But when it comes to booster shots, it's not as simple as "more ...

WASHINGTON, D.C. — President Joe Biden publicly received a COVID-19 booster shot Monday and encouraged all those eligible for a third dose to seek out a shot. At 78 years old, Biden qualified for a ...

Pfizer is seeking emergency use authorization for its COVID-19 booster vaccine shot for children ages 5 to 11. The company said it submitted its application to the Food and Drug Administration on ...

Moderna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its COVID-19 vaccine for people age 18 and older, and Pfizer and BioNTech ...